APA

Asnani M., Hayer K. E., Naqvi A. S., Zheng S., Yang S. Y., Oldridge D., Ibrahim F., Maragkakis M., Gazzara M. R., Black K. L., Bagashev A., Taylor D., Mourelatos Z., Grupp S. A., Barrett D., Maris J. M., Sotillo E., Barash Y. & Thomas-Tikhonenko A. (20200901). Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. : Leukemia.

Chicago

Asnani Mukta, Hayer Katharina E, Naqvi Ammar S, Zheng Sisi, Yang Scarlett Y, Oldridge Derek, Ibrahim Fadia, Maragkakis Manolis, Gazzara Matthew R, Black Kathryn L, Bagashev Asen, Taylor Deanne, Mourelatos Zissimos, Grupp Stephan A, Barrett David, Maris John M, Sotillo Elena, Barash Yoseph and Thomas-Tikhonenko Andrei. 20200901. Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. : Leukemia.

Harvard

Asnani M., Hayer K. E., Naqvi A. S., Zheng S., Yang S. Y., Oldridge D., Ibrahim F., Maragkakis M., Gazzara M. R., Black K. L., Bagashev A., Taylor D., Mourelatos Z., Grupp S. A., Barrett D., Maris J. M., Sotillo E., Barash Y. and Thomas-Tikhonenko A. (20200901). Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. : Leukemia.

MLA

Asnani Mukta, Hayer Katharina E, Naqvi Ammar S, Zheng Sisi, Yang Scarlett Y, Oldridge Derek, Ibrahim Fadia, Maragkakis Manolis, Gazzara Matthew R, Black Kathryn L, Bagashev Asen, Taylor Deanne, Mourelatos Zissimos, Grupp Stephan A, Barrett David, Maris John M, Sotillo Elena, Barash Yoseph and Thomas-Tikhonenko Andrei. Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. : Leukemia. 20200901.